Evidence map›Paper›PMID 26479416›Full record

ArticleTransplantation2015

Design and Implementation of the International Genetics and Translational Research in Transplantation Network.

International Genetics & Translational Research in Transplantation Network (iGeneTRAiN)

Open access · hybridAbstract read
In one paragraph

Article in Transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. KiT-GENIE, the French genetic biobank of kidney transplantation.European journal of human genetics : EJHG · 2023
    Article
  7. Article
  8. Frailty and genetic risk predict fracture after lung transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  9. Article
  10. Whole transcriptome profiling of prospective endomyocardial biopsies reveals prognostic and diagnostic signatures of cardiac allograft rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Observational
  11. Article
  12. Review
  13. Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
  14. Early detection of SARS-CoV-2 and other infections in solid organ transplant recipients and household members using wearable devices.Transplant international : official journal of the European Society for Organ Transplantation · 2021
    Review
  15. Article
  16. Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

International Genetics & Translational Research in Transplantation Network (iGeneTRAiN)
Hennepin County Medical Center · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Pharmacogenomics of Immune Suppressants in Kidney TransplantationU19AI070119 · NIAID · UNIVERSITY OF MINNESOTA · PI MATAS, ARTHUR J · 2006 to 2016
$17.1M
Viral Infections and Posttransplant MorbidityP01DK013083 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NEVINS, THOMAS E · 1986 to 2013
$14.9M
Molecular profiling and immunomodulatory interventionsU01AI063589 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHAKED, ABRAHAM NA · 2004 to 2009
$14.4M
Long-term Deterioration of Kidney Allograft FunctionU01AI058013 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MATAS, ARTHUR J · 2005 to 2010
$10.2M
Integrative Analysis of a GWAS Repository with EMRs from over 40,000 ChildrenU01HG006830 · NHGRI · CHILDREN'S HOSP OF PHILADELPHIA · PI HAKONARSON, HAKON · 2012 to 2014
$3.7M
Adult to Adult Living Donor Liver Transplantation Cohort StudyU01DK062494 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI OLTHOFF, KIM MARIE · 2002 to 2014
$3.3M
Gene Polymorphisms and Kidney Transplant OutcomeR01AI054115 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI OETTING, WILLIAM S · 2002 to 2005
$1.0M
Medical Research Council MR/K500999/1NHGRI NIH HHS U01 HG006830NIAID NIH HHS R01 AI054115NIAID NIH HHS U01 AI058013NIAID NIH HHS U01 AI063589NIAID NIH HHS U19 AI070119NIAID NIH HHS UM1 AI109565NIDDK NIH HHS P01 DK013083NIDDK NIH HHS U01 DK062494
6 · The paper itself

Abstract

backgroundGenetic association studies of transplantation outcomes have been hampered by small samples and highly complex multifactorial phenotypes, hindering investigations of the genetic architecture of a range of comorbidities which significantly impact graft and recipient life expectancy. We describe here the rationale and design of the International Genetics & Translational Research in Transplantation Network. The network comprises 22 studies to date, including 16494 transplant recipients and 11669 donors, of whom more than 5000 are of non-European ancestry, all of whom have existing genomewide genotype data sets.

methodsWe describe the rich genetic and phenotypic information available in this consortium comprising heart, kidney, liver, and lung transplant cohorts.

resultsWe demonstrate significant power in International Genetics & Translational Research in Transplantation Network to detect main effect association signals across regions such as the MHC region as well as genomewide for transplant outcomes that span all solid organs, such as graft survival, acute rejection, new onset of diabetes after transplantation, and for delayed graft function in kidney only.

conclusionsThis consortium is designed and statistically powered to deliver pioneering insights into the genetic architecture of transplant-related outcomes across a range of different solid-organ transplant studies. The study design allows a spectrum of analyses to be performed including recipient-only analyses, donor-recipient HLA mismatches with focus on loss-of-function variants and nonsynonymous single nucleotide polymorphisms.

Indexed as

Cooperative BehaviorInternational CooperationOrgan TransplantationResearch DesignDatabases, GeneticGenetic Association StudiesGenetic MarkersGenetic Predisposition to DiseaseGraft RejectionGraft SurvivalHumansModels, OrganizationalPhenotypePolymorphism, Single NucleotideRisk FactorsSample SizeGenetic Markers

Identifiers

PMID26479416
PMCPMC4623847
OpenAlexW2463912758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.